• FirefoxInstall the new Firefox »
  •  Dow Up 1.49% Nasdaq Up 1.15%

    CTI BioPharma Corp. (CTIC)

    -NasdaqCM
    1.87 Up 0.06(3.31%) Mar 30, 4:00PM EDT
    Add to Portfolio
    Prev Close:1.81
    Open:1.85
    Bid:1.88 x 10000
    Ask:1.89 x 9000
    1y Target Est:5.63
    Beta:1.64
    Earnings Date:Apr 27 - May 1 (Est.)
    Day's Range:1.84 - 1.88
    52wk Range:1.77 - 3.60
    Volume:1,583,491
    Avg Vol (3m):3,500,420
    Market Cap:324.83M
    P/E (ttm):N/A
    EPS (ttm):-0.65
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for CTIC

    Comparison

    Symbol% ChgMkt Cap
    CTICUp 3.31%324.83M
    BMYUp 0.77%109.30B
    RHHBYDown 0.12%N/A
    SNYUp 0.54%131.37B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):5.23
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.46
    Quarterly EPS Est (Mar-15) :-0.14
    Mean Recommendation*:1.5
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    CTI BioPharma Corp., a biopharmaceutical company, engages in the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States and internationally. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback